CoChat
Sign Up
Cited by 159Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program

Open access
Allocco, Dominic J, Cannon, Louis A, Britt, Amy, Heil, John E, Nersesov, Andrey, Wehrenberg, Scott, Dawkins, Keith D, Kereiakes, Dean J·2010·Trials
DOI 10.1186/1745-6215-11-1PMC PMC2826324
Open this paper in CoChat — free accountOpen PDF

Abstract

Background: Paclitaxel-eluting stents decrease angiographic and clinical restenosis following percutaneous coronary intervention compared to bare metal stents. TAXUS Element is a third-generation paclitaxel-eluting stent which incorporates a novel, thinner-strut, platinum-enriched metal alloy platform. The stent is intended to have enhanced radiopacity and improved deliverability compared to other paclitaxel-eluting stents. The safety and efficacy of the TAXUS Element stent are being evaluated in the pivotal PERSEUS clinical trials. Methods/Design: The PERSEUS trials include two parallel studies of the TAXUS Element stent in single, de novo coronary atherosclerotic lesions. The PERSEUS Workhorse study is a prospective, randomized (3:1), single-blind, non-inferiority trial in subjects with lesion length ≤28 mm and vessel diameter ≥2.75 mm to ≤4.0 mm which compares TAXUS Element to the TAXUS Express 2 paclitaxel-eluting stent system. The Workhorse study employs a novel Bayesian statistical approach that uses prior information to limit the number of study subjects exposed to the investigational device and thus provide a safer and more efficient analysis of the TAXUS Element stent. PERSEUS Small Vessel is a prospective, single-arm, superiority trial in subjects with lesion length ≤20 mm and vessel diameter ≥2.25 mm to <2.75 mm that compares TAXUS Element with a matched historical bare metal Express stent control. Discussion: The TAXUS PERSEUS clinical trial program uses a novel statistical approach to evaluate whether design and metal alloy iterations in the TAXUS Element stent platform provide comparable safety and improved procedural performance compared to the previous generation Express stent. PERSEUS trial enrollment is complete and primary endpoint data are expected in 2010. PERSEUS Workhorse and Small Vessel are registered at http://www.clinicaltrials.gov, identification numbers NCT00484315 and NCT00489541.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1745-6215-11-1

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PERSEUS WH and PERSEUS SV Study Schematic.
Figure 1 PERSEUS WH and PERSEUS SV Study Schematic.CC BY · PubMed Central
Figure 2 Strength and flexibility of the TAXUS Element stent compared to TAXUS Express and TAXUS Liberté stents. (A) Stent integrity, as measured by an accelerated life test of the bending fatigue of a stent in a simulated overlapped stent configuration, showing number of bend cycles before stent fracture. The test is conducted by mounting one end of a nominally deployed stent to a fixed mandrel while the other end is mounted to a mandrel suspended in a flexible membrane. The membrane mounted end of the stent is translated perpendicular to the longitudinal axis of the stent to impart a repeatable bend in the stent. (B) Conformability - a measure of the torque required to bend the stent to a specific curvature, which is directly related to flexibility of the stent. Lower required bending moment indicates increased flexibility. N = 15 for each stent type. Bars represent ± 1 standard deviation.
Figure 2 Strength and flexibility of the TAXUS Element stent compared to TAXUS Express and TAXUS Liberté stents. (A) Stent integrity, as measured by an accelerated life test of the bending fatigue of a stent in a simulated overlapped stent configuration, showing number of bend cycles before stent fracture. The test is conducted by mounting one end of a nominally deployed stent to a fixed mandrel while the other end is mounted to a mandrel suspended in a flexible membrane. The membrane mounted end of the stent is translated perpendicular to the longitudinal axis of the stent to impart a repeatable bend in the stent. (B) Conformability - a measure of the torque required to bend the stent to a specific curvature, which is directly related to flexibility of the stent. Lower required bending moment indicates increased flexibility. N = 15 for each stent type. Bars represent ± 1 standard deviation.CC BY · PubMed Central
Figure 3 (A) Express, Liberté, and Element stent architecture; (B) Radiographic comparison of Element and Express stents. Radiographic image was generated using a General Electric OEC 9800 Digital Imaging System at operating conditions of 51 kV and 11.66 mA. No anatomical simulating phantom was used during imaging.
Figure 3 (A) Express, Liberté, and Element stent architecture; (B) Radiographic comparison of Element and Express stents. Radiographic image was generated using a General Electric OEC 9800 Digital Imaging System at operating conditions of 51 kV and 11.66 mA. No anatomical simulating phantom was used during imaging.CC BY · PubMed Central
Figure 4 Fibrin deposition around stent struts following TAXUS stent implantation in porcine coronary arteries. Swine coronary arteries were implanted with overlapping bare metal or TAXUS Express, TAXUS Liberté, or TAXUS Element paclitaxel-eluting stents and examined at 30, 90, and 180 days using light microscopy. Peristrut fibrin deposition was evaluated by study pathologists and scored on a 0-3 scale where 0 = no visible fibrin, 1 = mild fibrin present, 2 = moderate fibrin present, 3 = extensive fibrin present. Trichrome stained sections, 200× plate magnification. See Seifert et al., 2007 for more detailed methods [29]. (A) Example specimens at 180 days showing peristrut fibrin deposition histology. Number of specimens in each category is shown as n/N. (B) Number of specimens with extensive fibrin deposition (score 3) at each timepoint. There were no significant differences among control bare metal stents in any of the studies.
Figure 4 Fibrin deposition around stent struts following TAXUS stent implantation in porcine coronary arteries. Swine coronary arteries were implanted with overlapping bare metal or TAXUS Express, TAXUS Liberté, or TAXUS Element paclitaxel-eluting stents and examined at 30, 90, and 180 days using light microscopy. Peristrut fibrin deposition was evaluated by study pathologists and scored on a 0-3 scale where 0 = no visible fibrin, 1 = mild fibrin present, 2 = moderate fibrin present, 3 = extensive fibrin present. Trichrome stained sections, 200× plate magnification. See Seifert et al., 2007 for more detailed methods [29]. (A) Example specimens at 180 days showing peristrut fibrin deposition histology. Number of specimens in each category is shown as n/N. (B) Number of specimens with extensive fibrin deposition (score 3) at each timepoint. There were no significant differences among control bare metal stents in any of the studies.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Turco M, Grube E: Taxus Clinical Update-Experts discuss the current role of the Taxus stent. Cardiac Intervent Today. 2008, September: 34-39.

Cited by

Sorted by citations

See all 159

Related

See all

Metadata

Authors
Allocco, D. J., Cannon, L. A., Britt, A., Heil, J. E., Nersesov, A., Wehrenberg, S., Dawkins, K. D., & Kereiakes, D. J.
Affiliations
  • Boston Scientific (United States) (US)
  • Cardiac And Vascular Research Center Of Northern Michigan (US)
  • Christ Hospital (US)
Corresponding author
Kereiakes, Dean J
ORCID
Venue
Trials
Publisher
Springer Science and Business Media LLC
Published
2010-01-07
Volume
11
Issue
1
Pages
1-1
ISSN
1745-6215 (ISSN-L)
DOI
10.1186/1745-6215-11-1
PMC
PMC2826324
OpenAlex
W2139043704
Cited by
159
References
28
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2022: 8 · 2021: 34 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 19 · 2013: 7 · 2012: 8
FWCI
9.77
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • University of Connecticut
  • Boston Scientific Corporation
  • Cordis
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
paclitaxel-eluting stents, de novo coronary lesions, percutaneous coronary intervention, restenosis
MeSH terms
Australia, Bayes Theorem, Cardiovascular Agents, Chromium Alloys, Coronary Artery Disease, Data Interpretation, Statistical, Humans, New Zealand, Platelet Aggregation Inhibitors, Platinum, Prospective Studies, Prosthesis Design, Research Design, Severity of Illness Index, Singapore, Time Factors, United States, Stents, Angioplasty, Balloon, Coronary, Single-Blind Method, Treatment Outcome, Coronary Angiography, Paclitaxel, Drug-Eluting Stents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review